Using a treat-to-target approach in children with polyarticular JIA

High rates of remission achieved after 12 months of treat-to-target. Introduction Juvenile idiopathic arthritis (JIA for short) is an umbrella term for arthritis of an unknown cause in children under the age of 16. JIA causes pain, swelling and stiffness in one or more joints, as well as other symptoms like extreme tiredness (fatigue). Polyarticular […]

Read More…

Recommendations for treat-to-target strategies in JIA

Expert guidance on general treatment approaches for children with juvenile idiopathic arthritis. INTRODUCTION Juvenile idiopathic arthritis, commonly referred to as JIA, is an umbrella term for a group of inflammatory arthritis conditions with unknown cause which begin in children before the age of 16. The types of arthritis that sit under this umbrella are shown […]

Read More…

Endpoint not met, but golimumab delivers improvement in JIA

Golimumab results in rapid improvement in children with active polyarticular JIA INTRODUCTION Juvenile idiopathic arthritis, commonly referred to as JIA, includes most types of arthritis seen in children before the age of 16. JIA is an umbrella term for a group of inflammatory arthritis conditions with unknown cause which begin in childhood. JIA causes pain, […]

Read More…